Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I indeed did, but I have no desire to have Mr. Gordon fix his mistakes, for if he does it solely for me than he leaves out the others as well. Mr. Gordon was not the only person to email me that day, so did many of his victims. His victims seemed hard-set on getting far more than their shares. They convinced me not to get my shares back. Nonetheless, even if I did, numbers are not the matter for that conglomerate of cheated investors.
Didn't "We" never receive shares purchased through Grant Gordon and GHL?
Here's a reminder of your claim:
"Over 10 years back I invested about $50,000 into CVBT/VT through Mr. Gordon's GHL. I still have yet to receive those shares..."
Did "We" forget?
The comedy never ends!! Hahaha
Maybe this will put it in perspective for people who seem oblivious to the failure of VT to make any media presence. Even during a global pandemic small businesses get more traffic in their store in one day than CVBT gets in a month. It takes no effort to visit the website and somehow we are still lagging behind restricted brick-and-mortar stores! Mr. Gordon drinks more litres of alcohol per day than we get website visits in a day! Who on earth calls that progress and success?
I meant we as in CVBT. I’m glad we are focusing on the real issues at hand though. It really shows that CVBT/VT wants to get the word out and is trying to get more investors as well as more publicity rather than steal money from the same investors. I’m sure our strategy will work, it’s worked for the last seven years just look at all the uhhhhh.....patents?
Dan's reaction when he checks his bank account and realizes he could have had $420MM in CVBT/VT shares
Perhaps you should look at their YouTube channel which has many more videos than just that one (all in the thousands and multiple in the tens of thousands and one almost in the hundreds of thousands), and nonetheless that video was uploaded prior to CVBT’s version. Furthermore, just to emphasize how far behind CVBT is compared to Dan: CVBT’s version of the video has 500 views, Dan’s has 80,000. We barely exist.
Nonsense. Your only video is stolen from cvbt and posted as zhittya. Dan should be locked up for fraud.
Again, please go to google trends and you will see that a huge majority of their traffic comes from organic searches (ie not payed for) I implore you to go there and study up. We can not be left in the dust!
You really think they'll be able to find TWO suckers to invest in Shittya? This is like reading the Sunday funnies in the newspaper. This is comical! Hahaha For someone who believes so highly in social media to believe that the TWO sucker investors (or anyone for that matter) wouldn't do a search on the web about the criminal in charges current and checkered past is absolutely hysterical! Hahahaha.....
You are completely correct. CVBT/VT cannot and will not compete with a criminal who pays a 3rd world country advertising company pennies to inflate Shittya's numbers. You would think the criminal in charge would pay this company to clear up his exquisite reputation on the web? Hahaha
Your right social media is not important whatsoever in our day-and-age; getting access to the media and coverage is absolutely useless and a waste of time that’s why no one advertises on the Super Bowl, that’s why no one advertises on google, that’s why some of the largest companies this world has ever seen have zero media presence. I’m glad you cleared it up, what’s the email to invest again?
I am willing to bet that out of the 250,000 unique people that view their website per year a couple invest and obviously they are able to use that money to expand, I wonder if there are any companies that gets 100 visits per year and is considered valuable other than from the words of liars. Furthermore, you must be quite old if you can’t access YouTube or other forms of social media to see just how dominant they are compared to us. We are losing and we are losing miserably. They have 70k views on a single webinar! When they live-streamed another webinar they got 14,000 views! They have an email list of over 10,000 people (as per themselves so take that with a grain of salt)! We cannot compete when we have 100 visits per year. Your right when they have 250k people per year they get pennies and when we have 100 people per year we get millions...you expect investors to believe that?
And what has this WORLD CLASS social media campaign with 10s of followers and no social and no media done for Zhittya?
A few nickles invested by the latest bingo winners?
The monopoly money investment from insider and friend of Montano, Laub and RMO?
Zilch, nada, goose egg, BIG ZERO!
Keep up the fantastic work Zhittya team.
I still await my first email.
I still await a video other than the reused CVBT Peter Jennings piece.
I still await an invitation to one of the amazing money shows.
When I invest, the only things I care about are tik tok vids, facebook likes, and page views. Ip means nothing. Management means nothing. That's why zhittya is such a great investment. Baaahaaahaaa.
You are completely right, my postings are on par with a social media campaign that is able to attain more than 250,000 unique visitors in a course of a single year, all with less posts than myself. You just emphasize all that I say, VT is dead in the water; they are being walked on because for every one person CVBT/VT gets, the competition gets 1000. But that doesn’t matter because anyone can play that game look I posted five times!
Maybe it deserves a sticky.
Let's get this clear.
Just so I understand. The supposed college dropout, that Dan begged to invest in CVBT, to the point Dan guaranteed Calvin's investment with his own personal shares was successful in getting Dan voted out by a 95% - 5% margin?
The same supposed college dropout that later used Dan's own shares against him to vote him out?
The same Calvin Wallen that posseses Dan's shares that are currently valued at $420 million by independent valuation company and major institutional investors?
I just want t make sure because it's hard to understand because Dan has been CEO of soooooo many companies. He has such a prestigious degree. There is no way way he could let himself be stripped naked of everything by such a loser.
I just want to make sure I understand because after seeing the explosive video where he was PUT IN HIS PLACE by the Delaware attorney and reading the deposition where Dan said GOD spoke to him. I don't know how that could happen.
After reading the process server's deposition about how Dan sped through parks and fields where children were playing, it is difficult to believe such a STABLE individual could have been bested by an under educated person.
I guess it's a hard pill to swallow. Lolol
Wow, I am now convinced that VT is going the right way! I am no longer worried that our own administration has said that we have non-existent money or that we have zero media presence or that we are losing lawsuits or that a clinical trial has yet to start or the massive lawsuits against our own leadership; we ousted Dan seven years ago what more could an investor ever want? Our administration must be incredibly incompetent if they think this is attractive to investors.
It’s unfortunate to hear that CVBT has “... ALL OF THAT NON-EXISTENT MONEY!!” as per own words, I wonder if your source tells you that same thing? Either our own leadership is admitting that we have no money in the bank or they never plan on completing clinical trials to assure that there will never be a pay off of that non-existent money. I don’t think my fellow investors are pleased to hear that our money is going into losing cases to Dan and when we lose that our money has somehow disappeared.
Perhaps this will put it into perspective:
For Dan’s company to get 5700 views in two days on a single YouTube video it would take CVBT/VT half of a century to do. For CVBT/VT to match what Dan’s company gets in a year it would take more than 2,000 years at current rates (taking rough data from googles trends). You call that successful? I call that a nobody company whose only following can be traced to the ten people who view this board every year. I am doubtful that anyone wants to invest in us when no one has even heard of us!! Perhaps we are just circle-selling stocks? Grant sells a thousand shares to Calvin at $3 and he sells it back to him? We are making big money!!!
All 6500 shareholders and not even 5% check the VT website once per year!!! There is also no evidence whatsoever that BigPharma is interested in VT; as usual dead in the water, even our own investors think so!!
I loved your post, JB2001. So much so I've taken the liberty of reposting it.
johnnyblades2001 Friday, 07/24/20 08:23:12 PM
Re: None 0
Post # of 2489
Let's get this clear. Just so I understand. The supposed college dropout, that Dan begged to invest in CVBT, to the point he guaranteed Calvin's investment with Dan's personal shares was successful in getting Dan voted out by a 95% - 5% margin?
The same supposed college dropout that later used Dan's own shares against him to vote him out?
The same Calvin Wallen that posseses Dan's shares that are currently valued at $420 million by independent valuation company and major institutional investors?
I just want t make sure because it's hard to understand because Dan has been CEO of soooooo many companies. He has such a prestigious degree. There is no way way he could let himself be stripped naked of everything by such a loser.
I just want to make sure I understand because after seeing the explosive video where he was PUT IN HIS PLACE by the Delaware attorney and reading the deposition where Dan said GOD spoke to him. I don't know how that could happen.
After reading the process server's deposition about how Dan sped through parks and fields where children were playing, it is difficult to believe such a STABLE individual could have been bested by an under educated person.
I guess it's a hard pill to swallow. Lolol
No, this is an infomercial.
Butterball, snr & Butterball, jnr's kid on biotech association
It lists all the major biotech companies in Nevada such as, emmmm, well there's, emmmmm, and of course, emmmmm.
Beyond funny!!!!!!!
I know. 2.5 years of failed predictions. Both sad & pathetic.
Let's get this clear. Just so I understand. The supposed college dropout, that Dan begged to invest in CVBT, to the point he guaranteed Calvin's investment with Dan's personal shares was successful in getting Dan voted out by a 95% - 5% margin?
The same supposed college dropout that later used Dan's own shares against him to vote him out?
The same Calvin Wallen that posseses Dan's shares that are currently valued at $420 million by independent valuation company and major institutional investors?
I just want t make sure because it's hard to understand because Dan has been CEO of soooooo many companies. He has such a prestigious degree. There is no way way he could let himself be stripped naked of everything by such a loser.
I just want to make sure I understand because after seeing the explosive video where he was PUT IN HIS PLACE by the Delaware attorney and reading the deposition where Dan said GOD spoke to him. I don't know how that could happen.
After reading the process server's deposition about how Dan sped through parks and fields where children were playing, it is difficult to believe such a STABLE individual could have been bested by an under educated person.
I guess it's a hard pill to swallow. Lolol
IT'S ACTUALLY A 6-FIGURE SUM PAID AT VT'S DISCRETION AFTER THEY PAY FOR CLINICAL TRIALS + G&A.
O O O O U C H!!
I HOPE FAT (SOUNDS LIKE) BAR-STEWARD HASN'T SPENT ALL OF THAT NON-EXISTENT MONEY!!
UNFORTUNATELY, HUNGRY HIPPO MONTANO WILL HAVE TO KEEP VIGILANTLY BILKING THE AGED OUT OF THEIR LIFE SAVINGS.
BUTTERBALL'S LOSING STREAK CONTINUES
WORTHLESS OTHER THAN THE TRANSACTIONS TAKING PLACE PRIVATELY AT $3-$7 PER SHARE.
THANKS JOHNNYMCGRIFFIN. NEVER A DULL MOMENT.
YES, THE ONLY PEOPLE PAYING ATTENTION TO VT IS BIG PHARMA & VT'S 6500+ SHAREHOLDERS.
Question 12: Which of these statements was NOT made by one of the members of Venturis Therapeutics’s leadership team at one of the annual shareholders meetings?
(By popular demand, (THE POPULATION IS MADE UP OF DAN "BUTTERBALL" MONTANO, JOHN SLAUB, JACK(OFF) FACOBS, & MAIL ORDER BRIDE) we are re-visiting this subject from Question 11 with new and different quotes. There's a link to Question 11 below if you did not see it the first time.)
A) Calvin Wallen III: "Dr. Meyerson has been published over 100 times, and information on him is available on the Internet. You can see his publications, track record, what he has done in the industry. He is a strong biotech influence on the company."" (2018)
B) Grant Gordon: "Alright, I'm a high school dropout, I can own that. And I'm an alcoholic and have been drinking continually for over 4 decades, it's just the way it is. And maybe I'm not the most reliable person on the planet. But that doesn't mean that when I tell you that Venturis is about to close on a huge sum of equity, or that the clinical trials are about to re-start, or that Calvin Wallen is innocent of the charges filed against him by the U.S. government for allegedly stealing $14 million from his previous company, it doesn't mean I'm not telling the truth. Because if I said it, I believe it to be true. Isn't that enough for all of you? Thank you." (2020)
WALLEN'S CASE IS OF COURSE BEING NEGOTIATED OUT AT PRESENT AT THE REQUEST OF THE CREDITOR WHO HE HAS FOUGHT WITH FOR OVER 3 YEARS. NICE TRY THOUGH.
SO LET ME UNDERSTAND. A HIGH SCHOOL DROPOUT "SCHOOLED" BUTTERBALL MONTANO & HAD HIS FAT ASS KICKED OUT OF CVBT/VT BY A 95%-5% MARGIN. WOW, HOW EMBARRASSING FOR EL GROSSO. IS THAT THE SAME GRANT GORDON WHO HAS RAISED 95% OF THE CASH FOR CVBT/VT OR IS IT A DIFFERENT GRANT GORDON.
I’m sure that out of the 5700 view in three days, their 250k visits on their one website per year (as per Google) and their ten thousand strong email list (according to themselves) versus our 50 website visits per year means that they are far more successful than we are. But your right, no one knows about us so we must be far more successful!
Apparently the 5700 people who watched this video in 2 days think otherwise. It looks like this video got more views in two days than CVBT/VT gets views on their website in a whole year. That says something about VT, they can’t compete with somebody who apparently has nothing!
Question 12: Which of these statements was NOT made by one of the members of Venturis Therapeutics’s leadership team at one of the annual shareholders meetings?
(By popular demand, we are re-visiting this subject from Question 11 with new and different quotes. There's a link to Question 11 below if you did not see it the first time.)
A) Calvin Wallen III: "Dr. Meyerson has been published over 100 times, and information on him is available on the Internet. You can see his publications, track record, what he has done in the industry. He is a strong biotech influence on the company."" (2018)
B) Grant Gordon: "Alright, I'm a high school dropout, I can own that. And I'm an alcoholic and have been drinking continually for over 4 decades, it's just the way it is. And maybe I'm not the most reliable person on the planet. But that doesn't mean that when I tell you that Venturis is about to close on a huge sum of equity, or that the clinical trials are about to re-start, or that Calvin Wallen is innocent of the charges filed against him by the U.S. government for allegedly stealing $14 million from his previous company, it doesn't mean I'm not telling the truth. Because if I said it, I believe it to be true. Isn't that enough for all of you? Thank you." (2020)
C) Calvin Wallen III: "We hope to the bring to the marketplace over the next 12 months news of what we are hoping to enjoy." (2016)
D) Jon Ross: "There is one employee being compensated in cash by the company." (2016)
E) Robert Schleizer: "The company had a net loss of $2.8 million in 2017." (2018)
F) Calvin Wallen: "We've been working hard." (2018)
(The correct answer is listed below)
This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
The correct answer is: (B). This was again easy, for two reasons. One, because Venturis Therapeutics did not hold a shareholders meeting in 2020--in violation of its bylaws and stated promises to shareholders. Two, because since Calvin Wallen's hostile takeover, Grant Gordon has never spoken at a shareholders meeting (Mr. Wallen probably doesn't dare risk it). If you chose any answer other than (B), you really haven't been paying attention.
For fun, let's go through and review each of these choices.
(A) I remember laughing out loud at this statement when Mr. Wallen made it, because in one paragraph it reveals Calvin Wallen's complete buffoonery. Breaking News: Dr. Meyerson's career has been in pharmaceuticals, not biotechnology. But to a dropout like Mr. Wallen who doesn't know a protein from a chemical, what's the difference? And I love that final sentence, "He's a strong biotech influence on the company." Boy is that ever a statement.
(C) This is another Calvin Wallen doozy that had me laughing out loud at the time he made it. File this one under, "A statement that reflects the quality of the mind it came from." If you have any idea what his confused mind was trying to say, please let us all know. Does anyone know if Calvin Wallen III went by the name Nigel Tufnel earlier in life?
(D) Yes, I also loved this Jon Ross statement, in response to a question posed by a shareholder. Mr. Ross's statement reflects the stench of the company...er, I mean strength, that they only were paying one employee in cash. Mr. Ross proved Calvin Wallen's point that if you want to look smarter, surround yourself with dumber people. Also, by some strange coincidence, it's the last time that Mr. Ross ever spoke at a shareholders meeting. I wonder why?
(E) This quote is significant because it's the only time during the Calvin Wallen era we've ever been told any financial information about the company. Of course, in the next sentence Mr. Schleizer also indicated that the company received a going concern qualification from its auditors.
(F) When Mr. Wallen told us in 2018 that "We've been working hard," every shareholder breathed a sigh of relief. Because based on the non-existent results from CVBT/Venturis, we were all wondering if anyone was actually working beyond the one employee being paid in cash. Thankfully Mr. Wallen re-assured us they were.
Maybe this is a good time to review what a high-placed Venturis Therapeutics insider who left the company had to say:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156885999
And here are the earlier questions in our series:
Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885
Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166
Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431
Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684
Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065
Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658
Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920
Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390
Question 9: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156702737
Question 10: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356
Question 11: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156983504
Don't you mean 'ever'. Stock is worthless and company is doing nothing. Same old 'news' being recirculated time and again, nothing new.
Zhittya Genesis Medicine
Below is a press release I found on a Zoom webinar that Zhittya is holding called, “Parkinson’s Disease: Therapeutic Angiogenesis as a Disease Modifying, Breakthrough Therapy?”
As a shareholder of CVBT/VT, is this something we're doing?
July 22, 2020 10:30 ET | Source: Zhittya Genesis Medicine Inc
LAS VEGAS, July 22, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Zoom Webinar on its potential breakthrough therapy to reverse the progression of Parkinson’s disease. Currently, no therapies on the market can halt or reverse this disorder. The webinar will be broadcasted on Monday August 3, 2020 at 1:00 PM Pacific time (4:00 PM Eastern). The webinar is available to all interested parties, free of charge. Zhittya is advancing upon what it believes could be a “disease modifying agent” that has the potential to slow down and possibly even reverse the inexorable decline seen in patients who suffer from this devastating disease.
To register for this webinar go to: zgmwebinars.com
Over the last five years, a new medical hypothesis has been proposed that Parkinson’s disease may be caused by vascular disruption in the areas of the brain which house the “dopamine-producing neurons”, those neurons which are the target of patients suffering from Parkinson’s disease. The concept is simply that the micro-vascularization in the brain is blocked or narrowed restricting the flow of needed blood to these neurons, resulting in the classical symptoms of Parkinson’s disease, including tremor and gait disturbances. Just as in the heart, blockage of coronary arteries can lead to angina and heart attacks, that same process is now thought to underlie the development of Parkinson’s disease.
A new medical imaging technology known as “functional MRI” will be discussed in the webinar and this technology can measure regional blood flow in the brain. Diagnostic imaging data showed diminished blood flow in the area of the brain where the dopamine-producing neurons reside (the substantia nigra region), with Parkinson’s disease patients showing only 50% of the blood flow compared to a healthy younger person. With only 50% of the blood that is needed, why would it be a surprise that those neurons do not perform up to standard?
Zhittya’s management has been developing a biological drug which in other US FDA clinical trials has demonstrated it can trigger “therapeutic angiogenesis” or the growth of new blood vessels in ischemic tissues. In animal studies, monkeys that were given experimental Parkinson’s disease and treated with Zhittya’s biological drug, stopped their motor skills decline and actually improved almost back to their completely normal movement abilities.
Zhittya has been given permission to start a Phase I “proof of concept” clinical trial in Mexico, where three ascending doses of its angiogenesis drug will be studied in patients with Parkinson’s disease. A similar study is under review by regulatory authorities in Estonia. Zhittya has also filed an Investigational New Drug (IND) application with the US FDA to advance its drug into a Phase I clinical trial.
Daniel C. Montano, CEO of Zhittya stated, “I believe we are truly on to something here. Over the last three years, we have continually uncovered data which enhances our belief that therapeutic angiogenesis might be a viable breakthrough treatment for Parkinson’s disease. If, as we believe, Parkinson’s disease is caused by micro-vascular disruption in the brain, we hope our molecule can do in the brain, what it has already demonstrated it can do in the US FDA heart trial, namely, grow new blood vessels.”
Dr. Jack Jacobs, President of Zhittya stated, “Millions of people around the world suffer from Parkinson’s disease. We believe we may have a breakthrough therapy for this disease, which is why we will be spending many millions of dollars to prove if we are right or wrong. In the monkey experiments that were done, our drug demonstrated a genuine disease modifying effect, by regenerating new dopamine neurons in the brain, and it is this activity that we believe led to the restoration of the animal’s motor skills. We do not know if in human clinical trials, the medical outcome will be the same, but what I do know is that we have to find out and we owe this to the millions of sufferers of this horrific disease.”
About Zhittya Genesis Medicine
Zhittya’s management has been working to advance these medicines for over 21 years and many millions of dollars have been expended in preclinical and clinical studies. Zhittya’s medicine initiates a biological process in the human body referred to as “therapeutic angiogenesis” and this process will only occur in diseased tissues that become ischemic due to a lack of blood flow. In those areas with insufficient blood flow, the drug stimulates the growth of new blood vessels, providing nourishment and removing metabolic waste products, thereby re-establishing normal cellular functions. Heart disease, stroke, peripheral artery disease (PAD) and diabetic foot ulcers are just some of the more obvious disorders the drugs can treat, but in fact, over 75 human diseases, including neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease, are thought to be caused by lack of blood flow to a specific tissue.
I have been a shareholder since 2010.
I get emails from Venturis board members from time to time and what I get leads me to believe a lot of what I read about the company is speculation and/or false. I know the company is still functioning although I also believe completing the financials to relist is not going to happen for some time.
Question 12:
What song was playing as Dan fled the process server, wrecklessly driving through parks and fields of children playing?
A) The Benny Hill theme
B) Ringling Brothers Circus theme
C) Unskinny Bop - Poison
D) Happy Being fat - Big Dee Irwin
The End of Venturis Therapeutics
With Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) losing a 7-figure binding arbitration judgment to its former CEO Dan Montano (and one of these days we'll learn the final amount once the judge issues his final ruling), this insolvent, illiquid, and thoroughly broken zombie company has finally reached the end of the road. I believe the doors of this zombie company get shut once and for all fairly soon.
While a 7-figure binding judgment would not necessarily be fatal for a viable company, I believe it is something Venturis (the textbook definition of a zombie company) will not survive for one fundamental reason: Because Venturis is not viable, has not been viable for over a decade, and can not raise the money needed to go forward. Why? Because no one is going to put money into a company where the controlling shareholder/CEO, Calvin Wallen III, is an accused crook who has been accused by the U.S. government of stealing $14 million from his previous company, and who has had credible repeated allegations of falsified books and records at companies he has been associated with. Indeed, I find it telling that Mr. Wallen has taken a scorched earth approach to delay, delay, delay his trial (with an assist from coronavirus). It's been 3 years now that Mr. Wallen has successfully delayed his day of reckoning...er, excuse me, his opportuniy to clear his (ahem) "good name." Let me ask you one question: If you genuinely thought you were innocent and would be exonerated at a trial of (falsely) stealing so much money, wouldn't you want that trial to be held yesterday? I would! I personally believe that the fact Mr. Wallen has done everything possible to delay his trial all but screams to the world, "I'm guilty!"
So let's talk about that case, because it's been a while. Mr. Wallen is accused by the U.S. government of stealing a total of $14 million from his former company, Tauren Exploration Inc., prior to its bankruptcy. This is speculation on my part, but having read a number of the filings in this case, I suspect that when Mr. Wallen knew the company was doomed due to the large drop in gas prices, he started stealing from the company, figuring that in bankruptcy no one would notice the missing sums (and I know I'm not the only one who believes that some of these monies were diverted to CVBT/Venturis). Tauren did file bankruptcy, but someone did notice that something was wrong--a major creditor who notified the bankruptcy trustee. As a result, the bankruptcy trustee hired forensic accountants to investigate, and lo and behold, they discovered a series of cash diversions totaling $14 million to external accounts controlled by Mr. Wallen for which they could find no justifiable business reasons. Further, they also found attempts by Mr. Wallen to cover up those diversions. In one of the filings by the U.S. government, they detail the dates, amounts, and unrelated bank accounts that the money was siphoned off to. That means that unbeknownst to Mr. Wallen, the government subpoenad bank records and accounting records of other entities to understand these transactions. It's all pretty damning, I must say, and it's hard to see how Mr. Wallen can have any sort of defense in the face of a third party independent expert (i.e. the forensic accountants) testifying what they found. Hence, why Mr. Wallen has taken a scorched earth approach to delay, delay, delay. His day of reckoning is coming, and having read the government filings, I don't see any way that he gets exonerated. Further, I spoke with a bankruptcy attorney in TX who is not connected to this case, to get his take on it. After a quick review, he said to me, "The government does not lose cases like this." Time will tell.
So let me ask a question: If you're an investor and otherwise like the Venturis story (except maybe the part where the company has not run a single clinical trial since 2007), and were inclined to invest, would you put a dime into a company where the dude in control is accused by the U.S. government of being a crook?
And thus, that is why Venturis has reached the end of the road. No one will put a dime into this broken zombie company. Mr. Wallen does not have the money, stolen or otherwise, to make Venturis viable, and no one will acquire it because the existing data is no longer usable for regulatory purposes. Venturis CEO Robert Schleizer stated at the shareholders meeting in 2018 that the company received a qualified opinion letter from its auditors, with a going concern qualification. It's over.
If you'd like to read about the various court cases where the U.S. government is pursuing Calvin Wallen and related entities, here are the links:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here's a lengthier discussion of why Humpty Dumpty (a.k.a. Venturis Therapeutics) is beyond repair:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
And here's what a Venturis insider revealed about what's really going on at this zombie company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
Good to see some press. Certainly not an info commercial. Dandee Dan is cringing as he reads the board and sees our optimism.
Living in a van down by the river?
News? hahahahaha! That's an infomercial.
I guess that's the best Venturis has got.
This only confirms how dire the situation is at this zombie company.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
And make sure to look at this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156885999
And Question 11 in our quiz series is a really good one:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156983504
Venturis Therapeutics in the news.
https://builtin.com/dallas/biotech-companies-in-dallas
Question 11: Which of these statements was NOT made by one of the members of Venturis Therapeutics’s leadership team at one of the annual shareholders meetings?
A) Robert Schleizer: "We will receive a qualified audit as a going concern." (2018)
B) Calvin Wallen III: "Everyone wants to know as much as they can [about Venturis]. We would like to tell everyone as much as we can. But the more we speak to, the more we expose ourselves to other entities pirating our science and our work. There are certain things we are just not allowed to talk about. Therefore we have to hold those things close to ourselves." (2019)
C) Calvin Wallen III: "We anticipate re-opening the clinical trials relatively soon." (2016)
D) Calvin Wallen III: “[One of our achievements is] integrating ourselves in the Dallas biotech community.” (2016)
E) Dr. Laurence Meyerson: “Severe CAD [clinical trial], in Phase IIa, resumes in the first half of 2019.” (2018)
F) Grant Gordon: “It’s incredible what Calvin has done here by drifting the listless ship, iceberg [mumbles], swimming [pause]…FDA better. Thank you.” (2020)
(The correct answer is listed below)
This is part of our new Venturis Therapeutics educational trivia series. Unlike our cheap imitators who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (and are now sorry we didn't).
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156608105
The correct answer is: (F). This was easy, for two reasons. One, because Venturis Therapeutics did not hold a shareholders meeting in 2020--in violation of its bylaws and stated promises to shareholders. Two, because since Calvin Wallen's hostile takeover, Grant Gordon has never spoken at a shareholders meeting (Mr. Wallen probably doesn't dare risk it). If you chose any answer other than (F), you haven't been paying attention.
For fun, let's go through and review each of these choices.
(A) Yes, Robert Schleizer stated it himself that Venturis received a qualified audit as a going concern. And nothing has changed materially for the better since then.
(B) Calvin Wallen himself has stated at multiple shareholders meetings that CVBT/Venturis was not going to be forthcoming with information about the company, in order to protect itself against hostile parties. And it hasn't been. Yet such "information" allegedly leaks out in "rumors" that are publicly shared (although good news rumors inevitably turn out to be false). Think about that. And review Question 10 in our quiz series if you're unclear what this might mean.
(C) Calvin Wallen has told us on more than one occasion (as have others) that the clinical trials would be resuming "soon." Not one clinical trial has been run since 2007. Mr. Wallen, would you care to define the word "soon" for us?
(D) I love this quote! Calvin Wallen told us what a great achievement it had been for Venturis to have successfully integrated itself into the Dallas biotech community. (There is one?) No further comment is necessary.
(E) Dr. Meyerson gave us a very specific date for the resumption of the Phase IIa trial. Maybe I missed it, but did that trial resume in 2019 as Dr. Meyerson indicated? What about in 2020?
Maybe this is a good time to review what a high-placed Venturis Therapeutics insider who left the company had to say:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156885999
And here are the earlier questions in our series:
Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885
Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166
Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431
Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684
Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065
Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658
Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920
Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390
Question 9: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156702737
Question 10: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356
I agree. I used to share an office building with CVBT in Las Vegas which spurred my investment. The company has value and hopefully the merits of our patience will payoff.
Exactly. This.
The science has not changed. The company has only improved upon the data. Added pre-clinical information. Licenced data from Merck.
As I said before. Multiple reputable investment banks have valued CVBT in the billions. The only thing ever preventing that was previous mismanagement
I get the company, since the beginning, has been a trainwreck of monumental proportions. Question: Were the benefits of the FGF-1 protein with regard to the heart, angiogenesis, pressure ulcers and decubitus ulcers, etc lies too? What about the German trials showing people at deaths door active and doing well? What about the 3 week timeframe for complete closure of bed sores? This is why I got behind CVBT in the first place. Dan Montano was a blowhard but the results seemed real...what about Peter Jennings? Was he lying too?
BEWARE (Updated): Someone's apparently trying to dump their Venturis Therapeutics stock onto unsuspecting investors, and given the reference to "GG" it may well be Grant Gordon. Venturis is an insolvent, illiquid, failed company that is facing imminent liquidation after having lost a 7-figure judgement. I believe anyone who purchases stock in this company through a private stock transaction (see posts #2373 and #2445) is going to lose 100% of their investment, and in near-record time.
Further, there is a pattern of "rumors" emering from Venturis which intensify for a period of time (like now), but which are almost always false. Make sure you read this posting from my quiz series, which through humor suggests what's really happening and why:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356
Make sure you also read about the company's imminent demise:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
You may also want to read about recent developments:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156636621
A public service message brought to you by Walhall.
Thanks for the info, they answer me when I inquire also. I have confidence in the new team, not with montano and his minions.
I forgot to add .. (SARC)
You forgot to mention the stellar media and social media campaign Shittya has. It’s awesome. Don’t believe me? Sit through a blue hair pitch. It outshines timeshare properties presentations.
I despise the new management so much that I am willing to sell my 100,000 shares for .10/share. It's real shares, I promise
Followers
|
39
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3647
|
Created
|
04/08/05
|
Type
|
Free
|
Moderators |
VENTURIS THERAPEUTICS (formerly Cardiovascular
Biotherapeutics or CVBT) is a dead, zombie company
that hasn't run a single clinical trial in nearly 15
years. Not even one patient (!) has been treated
since 2007. Venturis Therapeutics is insolvent,
illiquid, and is controlled and run by an individual
who was accused by the U.S government of
embezzling $14 million from his previous company.
Venturis' lawyer, Barry Cannaday of Dentons (one
of the largest law firms in the U.S.), withdrew from
representing Venturis in April 2021 because Dentons
is owed over $200,000 by Venturis, and Mr. Cannaday
attested that "there are currently no assets or
revenue streams" to pay Dentons. Yet anonymous
advocates for Venturis (who I personally believe are
the company's desperate leadership) lie about public
facts that are easily verifiable. One of the most
absurd false claims is that there are (allegedly) two
ongoing pivotal clinical trials (see that particular
false claim below). These "clinical trials" exist only
in cyberspace but not in the real world the rest of us
(including Dentons) live in. That said, enjoy the
entertainment that lies below. Hopefully it gives you
some good laughs - that's about all that's left from
this dead, zombie company. Enjoy!
VENTURIS THERAPEUTICS (VT) OVERVIEW
VT was almost bankrupted by the original
CEO, Daniel C. Montano, and was rescued by
Calvin Wallen, Grant Gordon and then CFO,
Mickael Flaa.
VT had almost $40,000,000 in debt & was
effectively insolvent. The board of directors
who replaced the Dan Montano cronies
rehabilitated VT so that today the company has
almost zero debt and an comprehensive patent
portfolio. Under the disasterous management
of Dan Montano, the company had zero
patents.
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage
biopharmaceutical company advancing novel
therapeutics to address diseases such as
diabetic wounds, severe ischemic heart disease
and
peripheral artery disease. Our pre-clinical
therapeutic programs include erectile
dysfunction,
infarct stroke, degenerative disk disease and
Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on
targeted delivery of next generation
molecules which will improve the quality of life
for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast
Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when
administered to ischemic organs and
tissues. These anatomical targets are shown in
our pipeline section of the website.
www.vt.care
VENTURIS THERAPEUTICS (VT) OVERVIEW
VT was almost bankrupted by the original
CEO, Daniel C. Montano, and was rescued by
Calvin Wallen, Grant Gordon and then CFO,
Mickael Flaa.
VT had almost $40,000,000 in debt & was
effectively insolvent. The board of directors
who replaced the Dan Montano cronies
rehabilitated VT so that today the company has
almost zero debt and an comprehensive patent
portfolio. Under the disasterous management
of Dan Montano, the company had zero
patents.
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage
biopharmaceutical company advancing novel
therapeutics to address diseases such as
diabetic wounds, severe ischemic heart disease
and
peripheral artery disease. Our pre-clinical
therapeutic programs include erectile
dysfunction,
infarct stroke, degenerative disk disease and
Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on
targeted delivery of next generation
molecules which will improve the quality of life
for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast
Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when
administered to ischemic organs and
tissues. These anatomical targets are shown in
our pipeline section of the website.
www.vt.care
VENTURIS THERAPEUTICS OVERVIEW
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage biopharmaceutical company advancing novel
therapeutics to address diseases such as diabetic wounds, severe ischemic heart disease and
peripheral artery disease. Our pre-clinical therapeutic programs include erectile dysfunction,
infarct stroke, degenerative disk disease and Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on targeted delivery of next generation
molecules which will improve the quality of life for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when administered to ischemic organs and
tissues. These anatomical targets are shown in our pipeline section.
vt.care
Venturis Therapeutics (VT) is
a biotechnology company based
in Dallas, Texas. VT has pivotal trials
ongoing in Ischemic Heart Disease &
Diabetic Foot Ulcers.
VT has a comprehensive patent
portfolio protecting its therapeutic
programs.
Venturis Therapeutics (VT) is
a biotechnology company based
in Dallas, Texas. VT has pivotal trials
ongoing in Ischemic Heart Disease &
Diabetic Foot Ulcers.
VT has a comprehensive patent
portfolio protecting its therapeutic
programs.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |